Best Lymphoma doctors in Israel: TOP 25 doctors

Leading lymphoma expert at Sourasky Medical Center with over 41 years of experience of specialized oncology experience.

• Associate Professor of Oncology at Tel-Aviv University
• ESMO Faculty member specializing in sarcoma and lymphoma
• Extensive research background with collaborations at Weizmann Institute
• Former head of the Division of Oncology at Sourasky
• Active member in ASCO and IASLC for oncology advancements

Dr. Ram Ron works at the renowned Sourasky Medical Center in Tel Aviv, bringing focused expertise to complex lymphoma cases.

• More than 24 years of experience of clinical experience in oncology
• Fellowship-trained in oncology for specialized knowledge
• Works within a large, multidisciplinary oncology department
• Provides both diagnosis and advanced treatment planning

Dr. El Hasid has performed over 300 bone marrow and umbilical blood transplants for children at Sourasky Medical Center.

• Leads the Department of Pediatric Oncohematology and Oncology at Dana Dwek Children's Hospital
• Specializes in pediatric bone marrow and umbilical blood transplantation
• Published 50 research papers in the medical field
• Member of the American Society of Hematology and Israeli Society for Pediatric Hematooncology
• Gained experience at the City of Hope Hospital in Los Angeles

He has performed several hundred stem cell transplants, a key treatment for lymphoma. Dr. Ron Ram is a triple board-certified oncologist at Sourasky Medical Center (Ichilov).

• Specializes specifically in Hematology and Medical Oncology
• Completed his oncology fellowship at New York Medical College
• Contributed to over 30 scientific articles and a medical textbook
• Experienced in both internal medicine and advanced hematologic cancers

Prof. Amos Toren, MD, PhD, MHA, is a pediatric hemato-oncologist and BMT specialist. He served as Director of Pediatric Hemato-Oncology and BMT at Sheba Medical Center.

He is board certified in Pediatrics, Pediatric Hemato-Oncology, and Bone Marrow Transplantation. He holds a PhD in Human Genetics. He was Head of the Hematology Division at Tel Aviv University for two terms. He is a member of ASH, COG, ESPHI, EBMT, and CIBMTR. He also serves on the Ministry of Health Cord Blood Committee.

He led one of Israel’s most advanced pediatric oncology and BMT programs. The program treated children and young adults. His focus includes leukemia and lymphoma, immunodeficiencies, and rare cancers. He specializes in BMT and CAR T-cell therapy.

His translational research covers CAR T cells, cytokine-induced killer cells, pediatric brain tumors, and targeted therapies. He has worked with St. Anna, the NIH, and St. Jude. His publications include studies on pediatric SCT prophylaxis and PARP resistance.

Head of Hematology and Lymphoma at Tel-Aviv Medical Center – Prof. Joffe specializes in complex lymphoma cases with advanced training at Memorial Sloan Kettering.

• 36 years of experience of experience in hematology-oncology
• Specializes in Diffuse Large B-Cell and CNS lymphomas
• Led clinical trials for new lymphoma immunotherapies
• Senior physician at Memorial Sloan Kettering Cancer Center
• Focuses on personalized treatment based on genetic profiling

Prof. Shapira specializes in bone marrow transplantation and leads the treatment team at Sourasky Medical Center.

• Graduated from Hebrew University's medical school in 1999
• Specialized in internal medicine at Hadassah Medical Center
• Previously a senior physician in a Bone Marrow Transplantation department
• Speaks English and Hebrew for clear communication

Heads the Hemato-Oncology Institute at Sourasky Medical Center – a major center for lymphoma and leukemia care since 2003.

• 34 years of experience of practice as an oncohematologist
• Specializes in treating lymphomas, not just general oncology
• Leads the Bone Marrow Transplantation Department

Dr. Dror Levin leads pediatric hematology oncology at Sourasky Medical Center, specializing in blood disorders and bone cancer in children.

• Senior pediatrician at Children's Hospital 'Dana' with extensive experience
• Coordinator for bone cancer (sarcoma) treatment in children
• Trained at Rizzoli Orthopaedic Institute in Bologna – a world leader in orthopedics
• Member of ISPHO (Israel Society of Pediatric Hematology Oncology)

Dr. Yair is a leading hematologist with multiple awards for excellence in lymphoma research and treatment at Tel-Aviv Sourasky Medical Center.

• Specializes in chronic lymphocytic leukemia cases
• Recipient of 10+ prestigious awards in hematology
• Member of both Israeli and American Hematology Associations
• Trained at top Israeli medical institutions

Recognized as one of Israel's best doctors by Forbes in 2019-2020, Dr. Gal Goldstein is the Head of Pediatric Oncology at Hadassah Hospital.

• Specializes exclusively in pediatric hemato-oncology for over 27 years of experience
• Expert in advanced treatments like haploidentical bone marrow transplants
• Deep focus on specific childhood cancers, including retinoblastoma
• Active member of international oncology societies like SIOP
• Employs precision medicine to personalize treatment plans

Dr. Hana Golan, MD, heads the Pediatric Hemato-Oncology and Bone Marrow Transplantation (BMT) Division at Sheba Medical Center. She specializes in childhood cancers, with a focus on neuroblastoma and other high-risk solid tumors.

She leads one of the region’s most advanced pediatric oncology programs. She manages complex, high-risk cases and practices at a hospital ranked in the global top 10.

She is the principal investigator of the High-Risk Neuroblastoma ESIOP protocol. She serves as an investigator in international Phase I/II trials and as the national coordinator of multicenter oncology protocols. She led the development of computerized chemotherapy protocols and patient databases to improve safety.

She earned her MD from the Technion. She completed residencies in pediatrics and pediatric hemato-oncology at Sheba. She conducted advanced research in transplantation immunology at the Weizmann Institute. She is board-certified in Pediatrics and Pediatric Hematology-Oncology. She is a Senior Lecturer at the Sackler Faculty of Medicine, Tel Aviv University. Her research focuses on cancer stem cells, targeted therapies, treatment-resistant malignancies, and cannabinoid-related oncology.

Dr. Hila Magen, MD, leads the Multiple Myeloma and Amyloidosis Unit at Sheba Medical Center. She is a hemato-oncologist with over 35 years of experience. She is a leading Israeli expert in multiple myeloma and plasma cell disorders.

She runs a program that provides personalized care and early access to clinical trials. This includes CAR-T therapy for high-risk and relapsed or refractory myeloma and amyloidosis. Dr. Magen is a principal investigator in point-of-care CAR-T studies. She brings new immunotherapies into routine care.

Training: Fellowships in Multiple Myeloma (UAMS) and Lymphocytic Leukemia (MD Anderson). Academic: Instructor, Tel Aviv University. Research: Author of 100+ publications, contributor to landmark myeloma studies, and reviewer for international journals.

Prof. Avichai Shimoni, MD, is Director of Bone Marrow Transplantation at Sheba Medical Center. He is a hemato-oncologist with over 30 years of experience in bone marrow transplantation, cellular therapies, and advanced blood cancer care.

He leads a high-volume program for complex, high-risk blood cancers. He performs allogeneic and autologous transplants. He also provides CAR T-cell therapy for leukemia, lymphoma, and multiple myeloma. He completed a bone marrow transplantation fellowship at MD Anderson Cancer Center.

He is Chairman of Hematology at Tel Aviv University and a Professor of Hematology. He has authored more than 250 scientific papers. His research focuses on CAR T-cell therapy and stem cell transplantation. He is often listed among Israel's Best Doctors (Forbes 2025 and 2026).

Dr. Abraham Avigdor, MD, is Director of the Institute of Hematology and Co‑Director of the Hematology & Bone Marrow Transplantation Division at Sheba Medical Center. He is an international leader in lymphoma, CAR‑T, and advanced hemato‑oncology with more than 35 years of experience. His clinical focus includes lymphomas, multiple myeloma, and complex blood cancers.

He is a pioneer in CAR‑T integration. He leads cellular therapy and bone marrow transplantation programs (autologous and allogeneic). He also advances stem cell therapies and precision diagnostics, including PET/CT‑based prognostics. His work includes immunotherapy and targeted regimens and the development of innovative, data‑driven protocols.

He collaborates with LYSA, EMCL, and international PET groups. He has authored more than 130 publications. Key roles include Founder and President of the Israeli Lymphoma Working Group, former Chair of the Israeli Lymphoma Study Group, and Senior Lecturer at Tel Aviv University. Education: MD, Ben‑Gurion University; residency, Sheba Medical Center; postdoctoral fellowship, Weizmann Institute. Awards include the Knesset Prize, the Israeli Ministry of Health Award, and the Sackler Prize.

Dr. Iris Kventsel, MD, is a pediatric hemato-oncologist and bone marrow transplant (BMT) specialist at Sheba Medical Center. She is an attending physician in the Pediatric Hemato-Oncology and BMT Division at the Edmond and Lily Safra Children’s Hospital. Her clinical focus is pediatric sarcomas, including Ewing sarcoma, osteosarcoma, and rhabdomyosarcoma.

She provides multidisciplinary care, including transplant and cellular therapies. She also uses current chemotherapy protocols and targeted therapies for complex childhood cancers.

Her research focuses on genetic cancer predisposition, including Li-Fraumeni syndrome, and cancer susceptibility genes. She has published in pediatric oncology, stem cell biology, and surgical oncology (HIPEC). She is on the academic staff at Tel Aviv University. Education: MD, Technion; Pediatrics residency, Assaf HaRofeh; Pediatric Hemato-Oncology fellowship, Sheba.

Prof. Elad Jacoby, MD, heads the Pediatric Cell Therapy Center at Sheba Medical Center. He is the Medical Director of the Advanced Biotherapy Center. He is a pioneer of pediatric CAR T‑cell therapy in Israel. He led one of the first national leukemia programs. He has almost 20 years of clinical and research experience.

He specializes in CAR T‑cell therapy, bone marrow and stem cell transplantation, and high‑risk pediatric leukemias and lymphomas. He leads international clinical trials and has authored over 240 publications. His collaborations include Johns Hopkins Hospital and the U.S. National Cancer Institute. He is an Associate Professor at Tel Aviv University. He received his MD from Tel Aviv University, completed residency at Sheba Medical Center, and fellowships at Johns Hopkins and the National Cancer Institute. He is board‑certified in Pediatrics and in Pediatric Hematology and Oncology. He serves on the IBFM CAR T‑Cell Taskforce and the Sheba Institutional Review Board. He leads the integration of CAR T‑cell therapy with transplantation.

Specializes exclusively in lymphoma, focusing his practice on this complex blood cancer at Rambam Medical Center.

• A hematologist with deep expertise in lymphoma subtypes
• Provides targeted treatments for this specific condition
• Based at a leading tertiary care and research hospital

Karen Drumea is a specialist in radiotherapy for oncology, focusing on treating cancer patients with radiation at Rambam Medical Center.

• Years of experience in radiation oncology and general oncology
• Specializes in using radiotherapy to treat cancers
• Based at Rambam Medical Center in Israel
• Combines expertise in both radiation and medical oncology for patient care